Search results
Why Moderna (MRNA) Stock Price Was Up 13% on Tuesday
Zacks via Yahoo Finance· 6 months agoShares of COVID-19 vaccine maker Moderna MRNA rose 13.1% on Jan 2, after analysts at Oppenheimer recently upgraded the stock’s recommendation to...
Moderna (MRNA) Stock Declines While Market Improves: Some Information for Investors
Zacks via Yahoo Finance· 1 day agoModerna (MRNA) ended the recent trading session at $137.90, demonstrating a -1.52% swing from the...
Moderna (MRNA) Q1 Earnings & Sales Top Estimates, Stock Up 2%
Zacks via Yahoo Finance· 1 year agoModerna MRNA reported earnings of 19 cents per share for the first quarter of 2023, beating the...
Moderna (MRNA) Beats on Q4 Earnings & Sales, Reiterates View
Zacks via Yahoo Finance· 4 months agoModerna, Inc. MRNA reported earnings of 55 cents per share in the fourth quarter of 2023, beating...
Moderna (MRNA) Soars 8.7%: Is Further Upside Left in the Stock?
Zacks via Yahoo Finance· 3 months agoModerna (MRNA) witnessed a jump in share price last session on above-average trading volume. The...
Moderna (MRNA) Outpaces Stock Market Gains: What You Should Know
Zacks via Yahoo Finance· 2 years agoModerna (MRNA) closed the most recent trading day at $165.69, moving +1.33% from the previous...
Why Moderna Stock Blasted 13% Higher Today
Motley Fool via Yahoo Finance· 2 months agoModerna (NASDAQ: MRNA) was a fine stock to heal an ailing portfolio on the second-to-last trading day of the week. The company, which developed and sells...
Moderna (MRNA) Beats on Q2 Earnings, Starts $3B Buyback Program
Zacks via Yahoo Finance· 2 years agoModerna, Inc. MRNA reported earnings of $5.24 per share for the second quarter of 2022, beating the...
Moderna (MRNA) Surges 3.2%: Is This an Indication of Further Gains?
Zacks via Yahoo Finance· 9 months agoModerna (MRNA) saw its shares surge in the last session with trading volume being higher than...
Moderna, Inc. (MRNA) Is a Trending Stock: Facts to Know Before Betting on It
Zacks via Yahoo Finance· 1 year agoModerna (MRNA) has received quite a bit of attention from Zacks.com users lately. Therefore, it is...